Social Capital Suvretta Holdings Corp. I (DNAA): Price and Financial Metrics


Social Capital Suvretta Holdings Corp. I (DNAA): $14.07

4.50 (+47.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DNAA Stock Price Chart Interactive Chart >

Price chart for DNAA

DNAA Price/Volume Stats

Current price $14.07 52-week high $17.44
Prev. close $9.57 52-week low $9.07
Day low $9.48 Volume 4,628,400
Day high $17.44 Avg. volume 182,488
50-day MA $9.98 Dividend yield N/A
200-day MA $9.91 Market Cap 360.75M

Social Capital Suvretta Holdings Corp. I (DNAA) Company Bio


Social Capital Suvretta Holdings Corp. I intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on a target business operating in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.


DNAA Latest News Stream


Event/Time News Detail
Loading, please wait...

DNAA Latest Social Stream


Loading social stream, please wait...

View Full DNAA Social Stream

Latest DNAA News From Around the Web

Below are the latest news stories about SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I that investors may wish to consider to help them evaluate DNAA as an investment opportunity.

Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox

BOSTON & SANTA MONICA, Calif., May 26, 2022--Akili Interactive ("Akili"), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, and Roblox (NYSE: RBLX), a global platform bringing millions of people together through shared experiences, today announced a collaboration that connects patients' medical treatments to their favorite virtual worlds.

Yahoo | May 26, 2022

Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit

BOSTON, April 04, 2022--Akili Interactive ("Akili" or the "Company"), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced that management will present at Chardan’s Prescription Digital Therapeutics Half-Day Summit on Monday, April 11, 2022 at 2:00 p.m. E.T.

Yahoo | April 4, 2022

Game Industry Veteran Behind Bejeweled, Plants vs. Zombies Joins Akili as Chief Product Officer

BOSTON, March 17, 2022--Akili Appoints Game Industry Veteran Jon David as Chief Product Officer

Yahoo | March 17, 2022

Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital Therapeutics

BOSTON, March 10, 2022--Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital Therapeutics

Yahoo | March 10, 2022

Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022

BOSTON, March 08, 2022--Akili has been named to Fast Company's Annual list of the World's 50 Most Innovative Companies

Yahoo | March 8, 2022

Read More 'DNAA' Stories Here

DNAA Price Returns

1-mo N/A
3-mo 42.26%
6-mo 42.54%
1-year 43.13%
3-year N/A
5-year N/A
YTD 41.69%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4953 seconds.